uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Theoretical predictions of drug absorption in drug discovery and development 
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. (Drug delivery)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. (Drug delivery)
Department of Chemistry, Medicinal Chemistry, Göteborg University.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. (Drug delivery)
2002 (English)In: Clinical Pharmacokinetics, ISSN 0312-5963, Vol. 41, no 11, 877-899 p.Article in journal (Refereed) Published
Abstract [en]

The clinical development of new drugs is often terminated because of unfavourable pharmacokinetic properties such as poor intestinal absorption after oral administration. Intestinal permeability and solubility are two of the most important factors that determine the absorption properties of a compound. Efficient and reliable computational models that predict these properties as early as possible in drug discovery and development are therefore desirable.

In this review, we first discuss the implementation of predictive models of intestinal drug permeability and solubility in drug discovery and development. Secondly, we discuss the mechanisms of intestinal drug permeability and computational methods that can be used to predict it. We then discuss factors influencing drug solubility and models for predicting it. We finally speculate that once these and other predictive computational models are implemented in drug discovery and development, these processes will become much more effective. Further, an increased fraction of drug candidates that are less likely to fail during clinical development will be selected.

Place, publisher, year, edition, pages
Adis International , 2002. Vol. 41, no 11, 877-899 p.
Keyword [en]
Clinical pharmacokinetics
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-102267PubMedID: 12190333OAI: oai:DiVA.org:uu-102267DiVA: diva2:214558
Available from: 2009-05-06 Created: 2009-05-06 Last updated: 2010-07-20Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ingentaconnect.com/content/adis/cpk/2002/00000041/00000011/art00005

Authority records BETA

Stenberg, PatricBergström, ChristelArtursson, Per

Search in DiVA

By author/editor
Stenberg, PatricBergström, ChristelArtursson, Per
By organisation
Department of Pharmacy
In the same journal
Clinical Pharmacokinetics
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 435 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf